about
Diagnosis of Mastocytosis in Children and Adults in Daily Clinical PracticeInfluences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish populationPregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis.European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.The influence of obesity on inflammation and clinical symptoms in asthma.Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations.Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.Interleukin-31 Polymorphisms and Serum IL-31 Level in Patients with Mastocytosis: Correlation with Clinical Presen-tation and Pruritus.Asthma prevalence and risk factors analysis in Tricity university students' group.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions.Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy.Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis.[Analysis of deaths caused by obstructive pulmonary diseases in Pomerania province in 2001-2004].Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients.[Fungal allergy--part II].Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis.Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.Association of mastocytosis with interleukin 31 gene polymorphism.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement.Clinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latex.[Side effects of specific immunotherapy in patients with hymenoptera venom allergy].[Mastocytosis--mastcell proliferative disease risk of anaphylactic reaction].Gene expression analysis in predicting the effectiveness of insect venom immunotherapy.The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens.Persistent impact of cigarette smoking on asthma.Differences in gene expression related to the results of obesity treatment, peak oxygen uptake and fatty acid metabolism measured in a cardiopulmonary exercise test.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.Asthma control uncontrolled.Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthmaClinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latexLate-phase allergic reaction in nasal provocation with fungal allergensAssociation between the -1154 G/A promoter polymorphism of the vascular endothelial growth factor gene and atopic dermatitis
P50
Q28081015-965AD69D-1CD9-4FB4-8CCA-D1B2FDB3FB2FQ33504408-6AA9B99C-2F9F-4EB1-A607-CFBC87B587A9Q35900583-F181EA51-F768-419D-8972-3EE3E78ABB49Q37377784-ADC36973-4EEF-4C87-A45B-155760F518F6Q38062360-812D1C2A-A292-46D6-B56A-59E9DF780BD8Q38111339-D0663FF1-2F60-495E-8BA1-9D9117AC7E2BQ38205505-372FC3F7-1A9E-4DD9-A7E2-0E4799A9011EQ38504083-79AC72EA-F869-4502-81D9-CE8B6350604BQ38609927-6A577493-B0AD-4B9B-9BCE-B77B028B542AQ39189663-5191C012-34FB-4444-949C-A530E3382F34Q39210394-7D69BE35-1001-4EB3-BE52-5733BB17EF1DQ39521294-EF44AE83-8F0F-479D-B116-2E95EF8C87C4Q39700675-CF191F9F-1F46-47C8-860B-E8FF2AC3EC1CQ40314330-C052A3D8-5E9F-4D33-9CD0-F4756876B1BBQ41690249-FF334390-5072-43FD-B320-012EBA910817Q42459109-07FEEF24-DE6D-40A4-A5CA-AE2027FF9CF0Q42923350-CCE2649E-0A5A-4468-813E-1ADBB303CA30Q43523062-026D6593-90D1-4C71-9EAB-CA4F28A6F22AQ44123691-0A5278DD-A46F-49DB-AFF1-7EBD9C724A3CQ44537932-9DAB3E9D-0448-4281-ADA6-62174607D246Q44594561-046861C2-8F13-40B7-9638-FBBD0BCD04B4Q46418767-C52BDADE-1E68-4AA0-B172-BCA746B14BB9Q46507238-875E3608-CB9C-4DD7-80D3-4DD08E9A3E80Q46948136-D52AACD6-21BA-46B2-9AC9-F6C0116A7DCDQ49391905-F7C5743D-F88B-4916-BA90-B9356F86279FQ51533907-D82D57BD-D619-4972-815A-460379835E05Q51754856-2775F706-744E-4B14-A12A-373E07087F06Q52672532-7AF3A386-9C36-43E0-A52D-7CC775F63C2CQ52678534-9CEE1D99-0761-41B2-BFDF-F58E5AE2E5EFQ52703656-C5D1FC54-7833-437D-8F95-2B43D8E54D74Q52704556-379A77FC-06B4-48CB-9C72-473608DB7C28Q53138852-B3AC84A6-C6E2-4598-A419-0FCB31DF224EQ53425758-6D8ACE9C-AEDD-481E-AE33-7A24959E58DAQ54261770-54956614-B1BB-4724-B187-E3A0CA2DF411Q54627727-4F276619-FF93-414E-9847-E8564BEB64C5Q55070195-0462936F-ED46-47D9-920D-934E2378C37FQ79785607-D2657388-C2B7-488A-AEDB-0478EB7D15D2Q80270283-50BA06BC-2858-456C-8DD2-C53FF2E2F46FQ80780345-14810926-3C35-4E59-8D88-C71FEF64B6DDQ84028710-6FC269A5-B1FE-41C8-9DCC-9CAE977E04E5
P50
description
Polish researcher
@en
Pools onderzoeker
@nl
cercetător polonez
@ro
chercheur polonais
@fr
investigador polaco
@es
investigador polaco
@gl
investigador polonès
@ca
polnischer Forscher
@de
polski naukowiec
@pl
ricercatore polacco
@it
name
Marek Niedoszytko
@ast
Marek Niedoszytko
@ca
Marek Niedoszytko
@en
Marek Niedoszytko
@es
Marek Niedoszytko
@fr
Marek Niedoszytko
@ga
Marek Niedoszytko
@gl
Marek Niedoszytko
@it
Marek Niedoszytko
@nl
Marek Niedoszytko
@pl
type
label
Marek Niedoszytko
@ast
Marek Niedoszytko
@ca
Marek Niedoszytko
@en
Marek Niedoszytko
@es
Marek Niedoszytko
@fr
Marek Niedoszytko
@ga
Marek Niedoszytko
@gl
Marek Niedoszytko
@it
Marek Niedoszytko
@nl
Marek Niedoszytko
@pl
prefLabel
Marek Niedoszytko
@ast
Marek Niedoszytko
@ca
Marek Niedoszytko
@en
Marek Niedoszytko
@es
Marek Niedoszytko
@fr
Marek Niedoszytko
@ga
Marek Niedoszytko
@gl
Marek Niedoszytko
@it
Marek Niedoszytko
@nl
Marek Niedoszytko
@pl
P214
P106
P1153
6603308598
P1412
P1559
Marek Niedoszytko
@pl
P21
P214
P27
P31
P496
0000-0003-1089-1911
P735
P7859
viaf-165100301